Baumer

Baumer CROIC

The Cash Return on Invested Capital (CROIC) of Baumer (BALM4.SA) as of Nov 9, 2026 is 11.93 %. In the previous year, Cash Return on Invested Capital (CROIC) was 11.33 % — a change of 5.33% (higher).

CROIC

11.93 %

YoY

5.33%

Last updated:

Cash Return on Invested Capital (CROIC) of Baumer is 2024 11.93 % . Cash Return on Invested Capital (CROIC) of Baumer was 2023 11.33 % . It decreases by 5.33% higher compared to the previous year.

The Baumer CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2017
3.39 BRL
Jan 1, 2018
-4.54 BRL
Jan 1, 2019
5.37 BRL
Jan 1, 2020
15.76 BRL
Jan 1, 2021
8.45 BRL
Jan 1, 2022
-1.85 BRL
Jan 1, 2023
11.33 BRL
Jan 1, 2024
11.93 BRL
The Baumer CROIC history
YEARCROICYoY
11.93 %+5.33%
11.33 %-712.38%
-1.85 %-121.90%
8.45 %-46.40%
15.76 %+193.32%
5.37 %-218.26%
-4.54 %-234.00%
3.39 %-331.32%
-1.47 %-212.76%
1.30 %+97.16%
0.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Cash Return on Invested Capital (CROIC) of Baumer is 11.93 % in 2024.

Cash Return on Invested Capital (CROIC) of Baumer changed from 11.33 % to 11.93 %, representing a 5.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Baumer since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Baumer with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Baumer

All Key Metrics — Baumer